Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Neuropathol Exp Neurol ; 46(2): 223-31, 1987 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3546601

RESUMO

The following report using light and electron microscopic and immunological techniques is based on a series of 19 Burmese patients who died of cerebral malaria. The principal change was blockage of cerebral capillaries by Plasmodium falciparum-infected erythrocytes. Ring hemorrhages and segmental necrosis of cerebral capillaries were common. Cerebral edema was variable in these cases. Electron-dense knobs, 40 X 80 nm in size, which protruded from the membrane of infected erythrocytes, formed focal junctions between endothelial cells and erythrocytes. These junctions resulted in the entrapment of erythrocytes and caused blockage in the capillary lumen. Immunoperoxidase study revealed that P. falciparum antigens and IgG deposits in the capillary basement membrane. This implies that damage to the cerebral capillary could be related to immune mechanisms.


Assuntos
Encefalopatias/patologia , Malária/patologia , Adolescente , Adulto , Membrana Basal/metabolismo , Membrana Basal/parasitologia , Encéfalo/parasitologia , Encéfalo/patologia , Encéfalo/ultraestrutura , Encefalopatias/parasitologia , Criança , Pré-Escolar , Feminino , Humanos , Imunoglobulina G/metabolismo , Malária/parasitologia , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Plasmodium falciparum/isolamento & purificação
2.
Artigo em Inglês | MEDLINE | ID: mdl-3313739

RESUMO

Sixty-six patients with complicated falciparum malaria (defined as anaemia, hyperpyrexia, jaundice, or more than 2% of RBC parasitised) were studied. Patients with cerebral signs and symptoms were not included in the study. Patients were randomised in pairs to receive either mefloquine 750 mg, sulfadoxine 1500 mg and pyrimethamine 75 mg (MSP) single oral dose or quinine (10 mg/kg tds X 7 days oral therapy). All the patients were admitted in hospital for 7 days and were followed on days 14, 21 and 28. All patients survived. The parasite clearance times in MSP treated patients were significantly shorter then those treated with quinine. There was no difference in fever clearance time in the two groups of patients. One patient was resistant to MSP at RII level and 5 patients were resistant at RI level. Among patients treated with quinine 3 patients were resistant at RI level.


Assuntos
Malária/tratamento farmacológico , Pirimetamina/uso terapêutico , Quinina/uso terapêutico , Quinolinas/uso terapêutico , Sulfadoxina/uso terapêutico , Sulfanilamidas/uso terapêutico , Adulto , Animais , Antimaláricos/administração & dosagem , Antimaláricos/uso terapêutico , Combinação de Medicamentos , Feminino , Humanos , Malária/complicações , Masculino , Mefloquina , Plasmodium falciparum , Estudos Prospectivos , Pirimetamina/administração & dosagem , Quinolinas/administração & dosagem , Sulfadoxina/administração & dosagem
4.
Lancet ; 335(8696): 1034-5, 1990 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-1970083
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA